Dr. Kithcart received his PhD on June 14 in Ohio Stadium from Ohio State President Dr. Gordon E. Gee.
His doctoral dissertation was titled, "Macrophage Migration Inhibitory Factor: A Key Mediator of Inflammatory Disease."
Kithcart's research led to the development of a new drug that will enter clinical trials in 2010. Following graduation, he will
continue at Ohio State to complete the remainder of his medical degree as part
of a combined MD/PhD program.
The Ohio State University is a world-class public research university and the
leading comprehensive teaching and research institution in the State of Ohio.
With more than 60,000 students, 18 colleges, and 170 majors, the university
offers its students tremendous breadth and depth of opportunity in the liberal
arts, the sciences, and the professions. Ohio State's Medical Center was
recently named one of the 21 best hospitals by U.S. News and
World Report and is consistently among the nation's top academic medical
Dr. Aaron Kithcart